Clinical Trials Directory

Trials / Unknown

UnknownNCT03400683

Different Methods of Termination of Second Trimester Abortion

Different Methods of Termination of Second Trimester Abortion: Comparative Clinical Study

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
150 (estimated)
Sponsor
Cairo University · Academic / Other
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Not accepted

Summary

The Patient are divided into 3 groups group 1 included 50 cases using misoprostol only. group 2 included also 50 cases in which using misoprostol with letrozole. Group3 included also 50 cases in which using misoprostol with Foleys catheter for termination of second trimesteric abortion between 14 and 24 weeks

Detailed description

Pregnant women were randomized into three equal groups: Group allocation was blindly randomized concealed by placement in numbered opaque sealed envelopes. These envelopes were kept in the labor ward and drawn in consecutive order: Group 'A" (misoprostol only group): Pharmacological method for termination of second trimester missed abortion was done by given 200 microgram misoprostol (Misotac 200 microgram tablet, Sigma Pharmaceuticals, Egypt), in sublingual every four hours for a maximum of five doses. Group 'B'(misoprostol with letrozole group): The anti-estrogen action of letrozole has been show to be useful in pretreatment for termination of pregnancy ,in combination with misoprostol,women in the letrozole group received 15mg( letrozole2.5mg) on three successive day patient take doses of letrozole for daily oral three successive day at home by herself and forth day admitted to our hospital followed by sublingual misoprostol 200 microgram misoprostol (Misotac 200 microgram tablet, Sigma Pharmaceuticals, Egypt), every four hours for a maximum of five doses. Group 'C' (misoprotol with Foley's catheter group): Mechanical method for termination of second trimester missed abortion was done using the transcervical 16F Foley's catheter with 30 ml balloon capacity (Euromed for Medical Industries, Cairo, Egypt, under license of Kanglite, USA), inserted under aseptic conditions withsublingual misoprostol 200 microgram misoprostol (Misotac 200 microgram tablet, Sigma Pharmaceuticals, Egypt), every four hours for a maximum of five doses.

Conditions

Interventions

TypeNameDescription
DRUGMisoprostol200 microgram misoprostol in sublingual every four hours for a maximum of five doses
DRUGLetrozole15mg( letrozole 2.5mg) on three successive day
PROCEDUREFoley's cathetertranscervical 16F Foley's catheter with 30 ml balloon capacity inserted under aseptic conditions

Timeline

Start date
2018-01-01
Primary completion
2018-06-01
Completion
2018-07-01
First posted
2018-01-17
Last updated
2018-01-25

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT03400683. Inclusion in this directory is not an endorsement.